Dataset from Phase II Study Of Single-Agent SU011248 In The Treatment Of Patients With Renal Cell Carcinoma
收藏NIAID Data Ecosystem2026-05-02 收录
下载链接：
https://doi.org/10.25934/00006802
下载链接
链接失效反馈官方服务：
资源简介：
To determine the objective tumor response of single-agent SU011248 at a dose of 50 mg orally
once daily for 4 consecutive weeks and 2 weeks rest, repeated every 6 weeks in patients with
metastatic Renal Cell Cancer (RCC).
创建时间：
2025-09-05
